Added to YB: 2021-08-09
Pitch date: 2021-08-09
OGN:US [bullish]
Organon & Co.
-69.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Organon & Co. develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
Market Cap
$3.4B
Pitch Price
$23.79
Price Target
N/A
Dividend
8.58%
EV/EBITDA
6.42
P/E
3.92
EV/Sales
1.83
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Organon & Co. OGN:US
A summary for this pitch has not been created yet.
Read full article (0 min)